This map shows the geographic impact of research published in Chemotherapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Chemotherapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chemotherapy more than expected).
This network shows the impact of papers published in Chemotherapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Chemotherapy.
About Chemotherapy
The 4.6k papers published in Chemotherapy in the last decades have received a total of 32.8k indexed citations . Papers published in Chemotherapy usually cover Molecular Medicine (733 papers), Pharmacology (1.1k papers), Applied Microbiology and Biotechnology (101 papers), Infectious Diseases (770 papers) and Microbiology (206 papers) specifically the topics of Antibiotics Pharmacokinetics and Efficacy (1.0k papers), Antibiotic Resistance in Bacteria (731 papers), Antimicrobial Resistance in Staphylococcus (346 papers), Pneumonia and Respiratory Infections (297 papers), Antifungal resistance and susceptibility (177 papers), Urinary Tract Infections Management (169 papers), Cancer therapeutics and mechanisms (163 papers) and Bacterial Identification and Susceptibility Testing (159 papers). The most active scholars publishing in Chemotherapy are G. Crovetti, Lorena Appio, Marco Bregni, Giovanni Serio, Martina Chiarucci, Carmelo Scarpignato, Rachel Airley, Ali Mobasheri, Walter H. Traub and Iva Pelosini.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.